NO822218L - Fremgangsmaate for inhibering av vekst av neoplastiske celler, samt farmasoeytisk preparat for anvendelse ved fremgangsmaaten - Google Patents

Fremgangsmaate for inhibering av vekst av neoplastiske celler, samt farmasoeytisk preparat for anvendelse ved fremgangsmaaten

Info

Publication number
NO822218L
NO822218L NO822218A NO822218A NO822218L NO 822218 L NO822218 L NO 822218L NO 822218 A NO822218 A NO 822218A NO 822218 A NO822218 A NO 822218A NO 822218 L NO822218 L NO 822218L
Authority
NO
Norway
Prior art keywords
procedure
inhibiting
growth
pharmaceutical preparation
neoplastic cells
Prior art date
Application number
NO822218A
Other languages
English (en)
Other versions
NO163595B (no
NO163595C (no
Inventor
Stanislaw R Burzynski
Original Assignee
Stanislaw R Burzynski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanislaw R Burzynski filed Critical Stanislaw R Burzynski
Publication of NO822218L publication Critical patent/NO822218L/no
Publication of NO163595B publication Critical patent/NO163595B/no
Publication of NO163595C publication Critical patent/NO163595C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/834—Urine; urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO822218A 1981-07-02 1982-06-29 Fremgangsmaate for fremstilling av forbindelsen 3-(n-fenylacetylaminopiperidin)-2,6-dion fra urin. NO163595C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27972881A 1981-07-02 1981-07-02
US06/330,383 US4470970A (en) 1981-07-02 1981-12-15 Purified antineoplaston fractions and methods of treating neoplastic disease

Publications (3)

Publication Number Publication Date
NO822218L true NO822218L (no) 1983-01-03
NO163595B NO163595B (no) 1990-03-19
NO163595C NO163595C (no) 1990-06-27

Family

ID=26959856

Family Applications (1)

Application Number Title Priority Date Filing Date
NO822218A NO163595C (no) 1981-07-02 1982-06-29 Fremgangsmaate for fremstilling av forbindelsen 3-(n-fenylacetylaminopiperidin)-2,6-dion fra urin.

Country Status (14)

Country Link
US (1) US4470970A (no)
EP (1) EP0069232B1 (no)
JP (3) JPH0729925B2 (no)
AU (1) AU551109B2 (no)
CA (1) CA1188218A (no)
DE (1) DE3273952D1 (no)
DK (2) DK162813C (no)
ES (1) ES512894A0 (no)
HK (1) HK30289A (no)
IL (1) IL65960A (no)
MY (1) MY102918A (no)
NO (1) NO163595C (no)
NZ (1) NZ200805A (no)
SG (1) SG4489G (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559325A (en) * 1981-12-15 1985-12-17 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4593038A (en) * 1985-04-03 1986-06-03 Burzynski Stanislaw R Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
US4705796A (en) * 1986-08-25 1987-11-10 Stereochemical Genetics, Inc. Use of 3-N-phenylacetylamino-2,6-piperidinedione for treatment of neuropsychiatric disorders
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
WO1991016309A1 (en) * 1990-04-12 1991-10-31 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
US5089508A (en) * 1990-09-04 1992-02-18 Burzynski Stanislaw R Methods for treating aids
US5116622A (en) * 1990-09-12 1992-05-26 Burzynski Stanislaw R Methods for treating parkinson's disease
US6037376A (en) * 1991-10-21 2000-03-14 The United States Of America As Represented By The Department Of Health And Human Services Methods for therapy of cancer
WO1993007866A2 (en) * 1991-10-21 1993-04-29 Dvorit Samid Compositions and methods for therapy and prevention of cancer, aids, and anemia
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
US5783605A (en) * 1995-02-27 1998-07-21 Kuo; Sheng-Chu Helper inducers for differentiation therapy and chemoprevention of cancer
ATE310505T1 (de) * 1996-05-14 2005-12-15 Stanislaw R Burzynski Liposomale antineoplaston therapie mit bemerkenswert verbesserter antineoplastischer aktivität
EP2298350A3 (en) * 1996-07-26 2011-06-08 Susan P. Perrine Composition comprising an inducing agent and an anti-viral agent for the treatment of viral disorders
US6258849B1 (en) 1998-07-23 2001-07-10 Stanislaw R. Burzynski Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
AU1553799A (en) * 1998-12-18 2000-07-12 Chang, Ming-Lieh Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof
US6987131B1 (en) * 2000-06-26 2006-01-17 Burzynski Stanislaw R Phenylacetic acid compositions for treating or preventing hypercholesterolemia
CN1802152A (zh) * 2002-08-01 2006-07-12 艾斯根公司 用谷氨酰胺改善癌症的治疗
US7087219B2 (en) * 2003-05-28 2006-08-08 Stanislaw R. Burzynski Toothpaste containing anticancer agents
US20060246016A1 (en) * 2003-05-28 2006-11-02 Burzynski Stanislaw R Toothpaste containing anticancer agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE463549A (no) *
GB2003887A (en) * 1977-09-06 1979-03-21 Nyegaard & Co As Isolation of peptides from urine
JPS57115330A (en) * 1981-01-08 1982-07-17 Toshiba Mach Co Ltd Forming process for thick plastic products and its metal mold
JP2897285B2 (ja) * 1989-10-19 1999-05-31 東洋紡績株式会社 熱可塑性樹脂フィルム積層物

Also Published As

Publication number Publication date
AU8423982A (en) 1983-01-06
EP0069232B1 (en) 1986-10-29
HK30289A (en) 1989-04-21
EP0069232A2 (en) 1983-01-12
JPH0532548A (ja) 1993-02-09
SG4489G (en) 1989-05-26
NO163595B (no) 1990-03-19
DK162813C (da) 1992-05-04
CA1188218A (en) 1985-06-04
ES8502417A1 (es) 1985-01-01
NO163595C (no) 1990-06-27
ES512894A0 (es) 1985-01-01
EP0069232A3 (en) 1984-07-04
IL65960A0 (en) 1982-09-30
JPH0739390B2 (ja) 1995-05-01
MY102918A (en) 1993-03-31
DK242082A (da) 1983-01-03
CA1262907C (no) 1989-11-14
DE3273952D1 (en) 1986-12-04
DK143491D0 (da) 1991-08-06
JPH0558886A (ja) 1993-03-09
JPH0729925B2 (ja) 1995-04-05
US4470970A (en) 1984-09-11
DK143491A (da) 1991-08-06
NZ200805A (en) 1986-08-08
AU551109B2 (en) 1986-04-17
IL65960A (en) 1985-11-29
DK162813B (da) 1991-12-16
JPH0780764B2 (ja) 1995-08-30
JPS5810521A (ja) 1983-01-21

Similar Documents

Publication Publication Date Title
NO822218L (no) Fremgangsmaate for inhibering av vekst av neoplastiske celler, samt farmasoeytisk preparat for anvendelse ved fremgangsmaaten
NO843515L (no) Fremgangsmaate for fremstilling av lipase, samt anvendelse av produktet
NO160629C (no) Fremgangsmaate for fremstilling av flytendegjort naturgass, samt system for utfoerelse av fremgangsmaaten.
DK164904C (da) Hydantoinderivater, fremgangsmaade til fremstilling deraf, herbicidt praeparat indeholdende forbindelserne samt anvendelse af forbindelserne ved bekaempelse af ukrudt
AR244222A1 (es) Procedimiento para la preparacion de nuevos derivados de arilfenileter y sus sales
ES513431A0 (es) "procedimiento para la preparacion de 1,2-a piridinas y pirazinas".
DK425583A (da) Fremgangsmaade til fremstilling af 4'-demethyl-epipodophyllotoxin-beta-d-ethylidenglycocid og acylderivater deraf samt mellemprodukt til brug ved fremgangsmaaden
NO832357L (no) Kirurgisk artikkel, samt fremgangsmaate for dens fremstilling
NO161862C (no) Polypropylen-materiale samt fremgangsmaate ved fremstilling av dette.
PH15662A (en) N2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
NO821128L (no) Fremgangsmaate ved fremstilling av titan, samt anordning for utfoerelse av fremgangsmaaten
DK181983D0 (da) 1,8-naphthyridin- og 1,5,8-azanaphthyridin-derivater, fremgangsmade til deres fremstilling samt deres anvendelse
NO881189L (no) Fremgangsmaate for fremstilling av klor samt reaktor for anvendelse ved fremstilling av klor.
NO172187C (no) Korrosjonsinhiberende preparat, fremgangsmaate for inhibering av korrosjon samt fremgangsmaate for fremstilling av det korrosjonsinhiberende preparat
NO159484C (no) Fremgangsm te for behandling av vann, samt innretniremgangsm tens utfoerelse.
NO883804D0 (no) Fremgangsmaate for fremstilling av fenolskum med lukkede celler.
NO842328L (no) Polyamidaminpolyaminer, samt fremgangsmaate ved fremstilling derav.
NO863468L (no) Fremgangsmaate og preparat for inhibering av korrosjon.
DE3260897D1 (en) Active corrosion-preventing pigments, process for their preparation and their use
NO902532L (no) Fremgangsmaate for fremstilling av flytebro, samt flytebrofortrinnsvis fremstillet i henhold til fremgangsmaaten.
IT8521570A0 (it) Procedimento di preparazione di microlattici invertiti ed i microlattici invertiti ottenuti.
NO831673L (no) Fremgangsmaate ved fremstilling av roerkokiller.
NO922241L (no) Vaatstyrke-harpiksblanding, samt fremgangsmaate for fremstilling av blandingen
NO844241L (no) Fremgangsmaate for konstruksjon av grunnmursfundament, samt forskaling til bruk ved fremgangsmaatens utfoerelse
TR23052A (tr) Reaktif boyalar,bunlarin hazirlanisi icin usul ve bunlarin kullanisi

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN JUNE 2002